Meteora Capital’s Estrella Immunopharma ESLA Stock Holding History

Meteora Capital’s Portfolio ESLA Stock Details ESLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,947	Closed	-$151K	–	381
2023 Q2	$151K	Sell	13,947 -10,987	-44%	-$119K	0.03%	207
2023 Q1	$263K	Sell	24,934 -5,999	-19%	-$62.7K	0.03%	215
2022 Q4	$318K	Buy	+30,933	New	+$315K	0.07%	151

Other funds holding ESLA

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Meteora Capital's ESLA Position: Q3 2023 in Review

Meteora Capital sold out of Estrella Immunopharma (ESLA) in Q3 2023, closing a stake of 13,947 shares — an estimated $151K sold.

Meteora Capital first reported a position in ESLA in Q4 2022 and held it in 3 quarters. The position peaked at $318K in Q4 2022. 3 funds tracked by Wall St. Rank hold ESLA as of Q3 2023.

Meteora Capital reported no remaining Estrella Immunopharma position as of Q3 2023 after selling out during the quarter.
Meteora Capital sold 13,947 Estrella Immunopharma shares in Q3 2023, an estimated $151K.
Meteora Capital first reported a position in Estrella Immunopharma in Q4 2022 and held it in 3 quarters.
Meteora Capital's Estrella Immunopharma position peaked at $318K in Q4 2022.
3 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2023.

Based on Meteora Capital's 13F filing for Q3 2023, filed 13 Nov 2023.